LIVN

LIVN

LivaNova PLC Ordinary Shares

$46.630+-0.000 (-0.000%)

Echtzeitkurs

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$46.630

Hoch

$46.630

Tief

$46.630

Volumen

0.67M

Unternehmensfundamentaldaten

Handelsstatistiken

Ähnliche Nachrichten

BusinessWire

CORE-VNS Study Further Validates Effectiveness of LivaNova's VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy

Long-term, real-world evidence demonstrates early and lasting outcomes of adjunctive VNS Therapy on severe focal seizures LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced

Mehr anzeigen
CORE-VNS Study Further Validates Effectiveness of LivaNova's VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy
BusinessWire

LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression

Final critical papers on RECOVER clinical study data accepted, supporting the Company's submission for coverage reconsideration Strong 24-month top-line data for RECOVER clinical study demonstrates durability of VNS

Mehr anzeigen
LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression
Analyst Upgrades

Wolfe Research Upgrades LivaNova to Outperform, Announces $60 Price Target

Wolfe Research analyst Mike Polark upgrades LivaNova from Peer Perform to Outperform and announces $60 price target.

Mehr anzeigen
Wolfe Research Upgrades LivaNova to Outperform, Announces $60 Price Target